OverviewSuggest Edit

Standigm is a company that applies AI technologies to drug discovery. It currently focuses on predicting new indications for existing drugs, called drug repositioning through the deeply trained AI model with molecular features of drug responses and drug uses.

Latest Updates

Employees (est.) (Jun 2021)32(+29%)

Standigm Office Locations

Standigm has an office in
Show all (2)

Standigm Financials and Metrics

Summary Metrics

Founding Date


Standigm total Funding

$59.7 m

Standigm latest funding size

$44.5 m

Time since last funding

3 months ago

Standigm investors

Standigm's latest funding round in March 2021 was reported to be $44.5 m. In total, Standigm has raised $59.7 m
Show all financial metrics

Standigm Online and Social Media Presence

Embed Graph

Standigm News and Updates

Standigm se asocia con Excelra parar GOSTAR

-Standigm se asocia con Excelra parar GOSTAR para mejorar su proceso de descubrimiento de fármacos impulsado por IA HYDERABAD, India y SEOUL, Corea del Sur, 15 de septiembre de 2020 /PRNewswire/ -- Excelra, una empresa global de ciencia de datos y análisis de datos, anunció hoy su...

Standigm s'associe à Excelra pour améliorer son processus de découverte de médicaments axé sur l'IA grâce à GOSTAR

HYDERABAD, Inde et SÉOUL, Corée du Sud, 15 septembre 2020 /PRNewswire/ -- Excelra, une entreprise mondiale spécialisée en science et en analyse des données, a annoncé aujourd'hui sa collaboration avec Standigm Inc., une entreprise qui utilise la technologie de l'intelligence artificielle...

Standigm verpartnert sich mit Excelra: GOSTAR optimiert den KI-gesteuerten Prozess der Arzneimittelentwicklung

HYDERABAD, Indien und SEOUL, Südkorea, 15. September 2020 /PRNewswire/ -- Excelra, ein weltweit tätiges Unternehmen für Datenwissenschaft und Datenanalyse, gab heute seine Zusammenarbeit mit Standigm Inc. bekannt, einem Unternehmen, das Künstliche Intelligenz (KI) für die Entdeckung und...

Standigm Blogs

Standigm Races AI Rivals To Become Global Discovery Contender

Executive Summary The South Korean AI-driven drug discovery venture is vying with global rivals in the space to show concrete validation of its approaches in partnered projects, while eyeing international expansion and new fundraising, its CEO says. AI Source: ShutterstockPURSUING DISCOVERY OF FIR…

Standigm Secures $44.5 M in Pre-IPO Funding Round

SEOUL, South Korea–(BUSINESS WIRE)–Standigm Inc. (“Standigm”), a leading Korean Artificial Intelligence (AI) company for drug discovery, announces today that it has closed $44.5 million in a pre-IPO funding round co-led by SKS PE and Daishin Private Equity. The round was joined by new investors in b…

Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

SEOUL, South Korea–(BUSINESS WIRE)–Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company and SK Chemicals Co., Ltd. (“SK Chemicals”), a life science and green chemicals company, announce today that they have successfully found a new rheumatoid arthritis indication …

Standigm and SK holdings C&C Release an AI-Based Target Identification Platform, iCLUE&ASK™, to Accelerate Drug Discovery Process

SEOUL, South Korea–(BUSINESS WIRE)–Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co., Ltd. (“SK holdings C&C”), a specialized Information and communications technology company, announced today that they opened their AI-based ta…

Standigm Frequently Asked Questions

  • When was Standigm founded?

    Standigm was founded in 2015.

  • How many employees does Standigm have?

    Standigm has 32 employees.

  • Who are Standigm competitors?

    Competitors of Standigm include Novadiscovery, Exscientia and BERG.

  • Where are Standigm offices?

    Standigm has an office in.

  • How many offices does Standigm have?

    Standigm has 2 offices.